Doximity Inc (DOCS) concluded trading on Wednesday at a closing price of $50.75, with 4.04 million shares of worth about $204.95 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 2.73% during that period and on May 21, 2025 the price saw a loss of about -4.25%. Currently the company’s common shares owned by public are about 137.78M shares, out of which, 129.79M shares are available for trading.
Stock saw a price change of -14.71% in past 5 days and over the past one month there was a price change of -3.15%. Year-to-date (YTD), DOCS shares are showing a performance of -4.94% which increased to 81.06% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $25.00 but also hit the highest price of $85.21 during that period. The average intraday trading volume for Doximity Inc shares is 2.75 million. The stock is currently trading -11.32% below its 20-day simple moving average (SMA20), while that difference is down -11.57% for SMA50 and it goes to -2.29% lower than SMA200.
Doximity Inc (NYSE: DOCS) currently have 137.78M outstanding shares and institutions hold larger chunk of about 68.71% of that.
The stock has a current market capitalization of $9.54B and its 3Y-monthly beta is at 1.34. PE ratio of stock for trailing 12 months is 45.82, while it has posted earnings per share of $1.11 in the same period. Its PEG reads 5.77 and has Quick Ratio of 6.92 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for DOCS, volatility over the week remained 5.46% while standing at 3.97% over the month.
Analysts are in expectations that Doximity Inc (DOCS) stock would likely to be making an EPS of 0.31 in the current quarter, while forecast for next quarter EPS is 0.35 and it is 1.62 for next year. For the current quarter EPS, analysts have given the company a lowest target 0.28 which is 0.39 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 0.28 in the same quarter a year ago. EPS is likely to shrink at an annualized rate of 7.94% for next 5-years, compared to annual growth of 79.45% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on February 07, 2025 offering an Overweight rating for the stock and assigned a target price range of between $31 and $78 to it. Coverage by Leerink Partners stated Doximity Inc (DOCS) stock as an Outperform in their note to investors on February 07, 2025, suggesting a price target of $90 for the stock. On December 20, 2024, Stephens Initiated their recommendations, while on December 04, 2024, Mizuho Initiated their ratings for the stock with a price target of $55. Stock get a Neutral rating from Goldman on November 15, 2024.
